“MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS”. 2023. Mediterranean Journal of Hematology and Infectious Diseases 15 (1): e2023047. https://doi.org/10.4084/MJHID.2023.047.